This Monday, Rocket VR (virtual reality) Health announced its participation in Newchip’s global accelerator program designed to fund, build, and scale start-ups and companies.
The Newchip Seed Accelerator provides Rocket VR Health with industry experts, mentors, and advisors that personally assist with the immersive firm’s global growth, according to Nik Vassev, COO and Co-Founder of Rocket VR Health, who added:
This partnership will allow us to continue developing innovative tools for patients at every step of their cancer journey.
The digital accelerator scheme is targeting more than 1,500 founders and firms. Newchip provides roughly $450 million in funding, creating a portfolio worth approximately $9 billion.
Newchip’s seed funding will help the healthcare firm generate traction and revenue. Armando Vera Carvajal, the Vice President of Product at Newchip added:
Innovative healthcare technology companies like Rocket VR Health can scale quickly with proper funding and guidance. We are excited for Rocket VR Health and believe they will be well positioned to take advantage of our fast-expanding global ecosystem at Newchip.
Immersive, Engaging Healthcare
Rocket VR Health is developing an immersive healthcare solution which distributes digital therapeutic courses to cancer patients and survivors.
It was great to join all the leading #VR innovators and community at our very first conference #AWE2022 pic.twitter.com/KZbe9OA4UK
— Rocket VR Health (@RocketVRHealth) June 4, 2022
The Rocket VR Health product utilises Pico brand headsets from parent company ByteDance to provide patients with rich therapeutic services.
The firm’s immersive therapy lasts four weeks. Rocket VR also supplies patients undergoing transplant therapy and social isolation with engaging immersive activities to assist with recovery periods.
The service also incorporates outdoor-styled VR environments where patients can enjoy digital activities such as gaming, wellness, and on-demand therapy.
In March, Massachusetts General Hospital partnered with Rocket VR Health to co-develop clinical therapies for cancer patients.
The partnership also supports the development of immersive solutions for patients undergoing hematopoietic stem cell transplantation (HCT) treatments. Often, HCT patients become bedridden, and Rocket VR Health’s product aims to improve the quality of life for these individuals undergoing HCT treatments at the Massachusetts location.
